Table 3.
Cancer type | Cases | Methoda | HRb | 95% CIb | Pb | Corrected Pc |
---|---|---|---|---|---|---|
Bladder cancer | 526 | Circulating vitamin E-based GRS | 0.86 | 0.05, 14.64 | 0.918 | 0.983 |
One-sample weighted GRS | 0.70 | 0.28, 1.75 | 0.444 | 0.989 | ||
One-sample unweighted GRS | 0.75 | 0.29, 1.93 | 0.551 | 0.988 | ||
Breast cancer | 4350 | Circulating vitamin E-based GRS | 2.30 | 0.86, 6.14 | 0.096 | 0.337 |
One-sample weighted GRS | 1.06 | 0.82, 1.36 | 0.674 | 0.989 | ||
One-sample unweighted GRS | 1.06 | 0.82, 1.38 | 0.664 | 0.988 | ||
Colorectal cancer | 2621 | Circulating vitamin E-based GRS | 0.43 | 0.12, 1.54 | 0.194 | 0.400 |
One-sample weighted GRS | 1.19 | 0.79, 1.80 | 0.404 | 0.989 | ||
One-sample unweighted GRS | 1.22 | 0.80, 1.87 | 0.348 | 0.988 | ||
Esophagus cancer | 460 | Circulating vitamin E-based GRS | 14.06 | 0.72, 275.16 | 0.082 | 0.337 |
One-sample weighted GRS | 1.01 | 0.38, 2.69 | 0.989 | 0.989 | ||
One-sample unweighted GRS | 0.99 | 0.36, 2.72 | 0.988 | 0.988 | ||
Lung cancer | 1700 | Circulating vitamin E-based GRS | 0.79 | 0.16, 3.89 | 0.772 | 0.983 |
One-sample weighted GRS | 1.17 | 0.70, 1.96 | 0.542 | 0.989 | ||
One-sample unweighted GRS | 1.16 | 0.69, 1.97 | 0.573 | 0.988 | ||
Oral and pharynx cancer | 458 | Circulating vitamin E-based GRS | 1.03 | 0.05, 21.74 | 0.983 | 0.983 |
One-sample weighted GRS | 0.93 | 0.35, 2.50 | 0.891 | 0.989 | ||
One-sample unweighted GRS | 0.87 | 0.32, 2.39 | 0.792 | 0.988 | ||
Ovarian cancer | 437 | Circulating vitamin E-based GRS | 2.09 | 0.09, 47.08 | 0.644 | 0.983 |
One-sample weighted GRS | 0.87 | 0.39, 1.92 | 0.724 | 0.989 | ||
One-sample unweighted GRS | 0.86 | 0.38, 1.96 | 0.722 | 0.988 | ||
Pancreatic cancer | 506 | Circulating vitamin E-based GRS | 1.08 | 0.06, 20.08 | 0.960 | 0.983 |
One-sample weighted GRS | 0.94 | 0.37, 2.41 | 0.898 | 0.989 | ||
One-sample unweighted GRS | 0.96 | 0.37, 2.52 | 0.934 | 0.988 | ||
Prostate cancer | 4882 | Circulating vitamin E-based GRS | 0.54 | 0.21, 1.39 | 0.200 | 0.400 |
One-sample weighted GRS | 0.93 | 0.72, 1.19 | 0.572 | 0.989 | ||
One-sample unweighted GRS | 0.97 | 0.75, 1.26 | 0.840 | 0.988 | ||
Kidney cancer | 649 | Circulating vitamin E-based GRS | 0.11 | 0.01, 1.54 | 0.101 | 0.337 |
One-sample weighted GRS | 0.68 | 0.30, 1.57 | 0.370 | 0.989 | ||
One-sample unweighted GRS | 0.73 | 0.31, 1.70 | 0.466 | 0.988 |
aCirculating vitamin E-based GRS, derived from three circulating vitamin E-SNPs; one-sample weighted and unweighted GRS, derived from dietary vitamin E-SNPs (P-value ≤ 5×10-5)
bAdjusted for sex, age, study centers, body mass index (BMI), smoking status, drinking status, and first ten principal components when appropriate
cThe corrected P-value was calculated with false discovery rate (FDR) method